Roche Holding AG Virtual Analyst Event During ESMO IO Transcript
Ladies and gentlemen, welcome to Roche virtual event on analyst during ESMO IO. My name is Henrik, and I'm the technical operator for today's call. Kindly note that the webinar is being recorded. (Operator Instructions)
At this time, it's my pleasure to introduce you to Karl Mahler, Head of Investor Relations and Group Planning. Karl, the stage is yours.
Yes. Thanks a lot, Henrik, for your kind introduction. Welcome to our ninth, actually, science call this year. So 9 events means that we really have lots of news flow -- positive news flow in the case of Roche, and this one is a particularly exciting one despite it's only in a Phase II (inaudible) only in a Phase II. And we have next week our last one in the course of ASH, where we basically testimony our broad and maybe best-in-class portfolio in hematology.
This is the program for today. We will have an updated -- and show to you an updated analysis from the Phase II CITYSCAPE study. Raymond Meng will do that. He is the Global Development Leader
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
